CEPH Insider Trading
CEPH | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at CEPH provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2006-12-22 21:58 | 2006-12-22 | BALDINO FRANK JR | Director, Officer - Chairman & CEO | SELL | $69.25 | 20,000 | $1,385,000 | 374,161 | -5.1% |
| 2006-09-06 21:52 | 2006-09-05 | GREENACRE MARTYN D | Director | OPT+S | $58.02 | 5,000 | $290,084 | 0 | 0.0% |
| 2006-03-04 00:12 | 2006-03-01 | ROCHE ROBERT P JR | Officer - Exec VP, Worldwide Pharm Ops. | OPT+S | $80.04 | 80,500 | $6,443,453 | 41,980 | 0.0% |
| 2006-03-03 00:15 | 2006-03-01 | SAVINI CARL A | Officer - Exec VP & Chief Admin Officer | OPT+S | $80.23 | 2,500 | $200,575 | 36,000 | 0.0% |
| 2006-03-03 00:15 | 2006-03-01 | SAVINI CARL A | Officer - Exec VP & Chief Admin Officer | OPT+S | $80.14 | 56,500 | $4,528,164 | 38,500 | 0.0% |
| 2006-03-01 01:55 | 2006-02-24 | GREBOW PETER E | Officer - Exec VP,Worldwide Tech Ops. | OPT+S | $76.41 | 9,800 | $748,853 | 48,435 | 0.0% |
| 2006-03-01 01:55 | 2006-02-24 | GREBOW PETER E | Officer - Exec VP,Worldwide Tech Ops. | OPT+S | $76.52 | 35,200 | $2,693,370 | 58,235 | 0.0% |
| 2006-03-01 02:01 | 2006-02-27 | BALDINO FRANK JR | Director, Officer - Chairman & CEO | OPT+S | $80.47 | 103,098 | $8,296,781 | 293,673 | 0.0% |
| 2006-02-23 01:11 | 2006-02-17 | ROCHE ROBERT P JR | Officer - Exec VP, Worldwide Pharm Ops. | OPT+S | $74.09 | 30,550 | $2,263,450 | 41,980 | 0.0% |
| 2006-02-23 01:11 | 2006-02-17 | GREENACRE MARTYN D | Director | OPT+S | $74.45 | 15,000 | $1,116,686 | 0 | 0.0% |
| 2006-02-23 01:10 | 2006-02-17 | BUCHI J KEVIN | Officer - Sr. Vice President and CFO | OPT+S | $74.40 | 29,073 | $2,163,127 | 83,848 | 0.0% |
| 2006-02-23 01:11 | 2006-02-17 | GREBOW PETER E | Officer - Exec VP,Worldwide Tech Ops. | OPT+S | $73.32 | 10,000 | $733,173 | 63,765 | 0.0% |
| 2006-02-23 01:11 | 2006-02-17 | SAVINI CARL A | Officer - Sr VP & Chief Admin Officer | OPT+S | $74.21 | 49,185 | $3,649,935 | 36,000 | 0.0% |
| 2006-02-23 01:12 | 2006-02-21 | WITZEL HORST | Director | OPT+S | $74.10 | 60,000 | $4,445,880 | 0 | 0.0% |
| 2006-02-23 01:12 | 2006-02-21 | OSBORN JOHN E | Officer - Sr. VP, General Counsel & Sec. | OPT+S | $73.87 | 4,818 | $355,883 | 36,000 | 0.0% |
| 2006-02-23 01:12 | 2006-02-17 | OSBORN JOHN E | Officer - Sr. VP, General Counsel & Sec. | OPT+S | $74.18 | 48,528 | $3,599,831 | 40,818 | 0.0% |
| 2006-02-23 01:12 | 2006-02-17 | OSBORN JOHN E | Officer - Sr. VP, General Counsel & Sec. | OPT+S | $74.17 | 40,597 | $3,011,185 | 47,721 | 0.0% |
| 2006-02-23 01:12 | 2006-02-17 | VAUGHT JEFFRY L | Officer - Sr. Vice Pres., and Pres., R&D | OPT+S | $74.46 | 37,900 | $2,822,212 | 45,502 | 0.0% |
| 2006-02-23 01:10 | 2006-02-17 | BLAKE PAUL | Officer - Exec VP, Clin Res & Reg Aff | SELL | $74.52 | 6,938 | $517,016 | 40,000 | -14.8% |
| 2006-02-23 01:11 | 2006-02-21 | EGAN WILLIAM P | Director | OPT+S | $73.98 | 10,000 | $739,797 | 0 | 0.0% |
| 2005-11-09 19:27 | 2005-11-08 | BUCHI J KEVIN | Officer - Sr. Vice President and CFO | OPT+S | $46.51 | 8,400 | $390,660 | 71,580 | 0.0% |
| 2005-09-21 21:52 | 2005-09-19 | ROCHE ROBERT P JR | Officer - Exec VP, Worldwide Pharm Ops. | SELL | $45.76 | 2,500 | $114,400 | 36,570 | -6.4% |
| 2005-06-06 23:57 | 2005-06-06 | FEENEY ROBERT J | Director | OPT+S | $39.68 | 10,000 | $396,840 | 0 | 0.0% |
| 2005-05-18 19:15 | 2005-05-17 | BALDINO FRANK JR | Director, Officer - Chairman & CEO | SELL | $44.22 | 25,373 | $1,122,060 | 324,945 | -7.2% |
| 2005-05-09 23:11 | 2005-05-09 | EGAN WILLIAM P | Director | SELL | $45.49 | 5,000 | $227,474 | 0 | -100.0% |
| 2005-03-07 17:21 | 2005-03-04 | VAUGHT JEFFRY L | Officer - Sr. Vice Pres., and Pres., R&D | OPT+S | $49.65 | 14,000 | $695,169 | 32,987 | 0.0% |
| 2005-02-23 22:31 | 2005-02-23 | ROCHE ROBERT P JR | Officer - Exec VP, Worldwide Pharm Ops. | SELL | $50.28 | 5,389 | $270,978 | 39,300 | -12.1% |
| 2005-02-18 19:41 | 2005-02-18 | FEENEY ROBERT J | Director | OPT+S | $50.35 | 25,000 | $1,258,783 | 0 | 0.0% |
| 2004-12-18 03:11 | 2004-12-15 | OSBORN JOHN E | Officer - Sr. VP, General Counsel & Sec. | OPT+S | $48.44 | 24,149 | $1,169,681 | 30,513 | 0.0% |
| 2004-12-18 03:12 | 2004-12-17 | BLAKE PAUL | Officer - Sr VP, Clin Research & Reg Aff | SELL | $49.28 | 3,469 | $170,952 | 36,531 | -8.7% |
| 2004-12-14 23:30 | 2004-12-13 | OSBORN JOHN E | Officer - Sr. VP, General Counsel & Sec. | SELL | $48.00 | 10,000 | $480,000 | 16,662 | -37.5% |
| 2004-12-15 00:39 | 2004-12-13 | OSBORN JOHN E | Officer - Sr VP, General Counsel & Sec. | SELL | $48.06 | 10,000 | $480,600 | 16,662 | -37.5% |
| 2004-12-03 23:10 | 2004-12-02 | GREBOW PETER E | Officer - Sr VP, Worldwide Technical Ops | OPT+S | $48.23 | 28,600 | $1,379,395 | 38,921 | 0.0% |
| 2004-11-09 19:18 | 2004-11-08 | BALDINO FRANK JR | Director, Officer - Chairman & CEO | OPT+S | $49.61 | 100,000 | $4,960,600 | 272,149 | 0.0% |
| 2004-03-24 00:57 | 2004-03-23 | ROCHE ROBERT P JR | Officer - Sr. V.P., Pharmaceutical Ops. | SELL | $55.60 | 2,500 | $139,009 | 28,603 | -8.0% |
| 2004-03-19 18:53 | 2004-03-19 | EGAN WILLIAM P | Director | SELL | $56.14 | 5,000 | $280,704 | 0 | -100.0% |
| 2004-03-16 23:20 | 2004-03-16 | WITZEL HORST | Director | OPT+S | $55.49 | 10,000 | $554,875 | 0 | 0.0% |
| 2004-03-03 22:34 | 2004-03-03 | VAUGHT JEFFRY L | Officer - Sr. VP, and Pres., R & D | SELL | $59.16 | 8,046 | $475,961 | 20,901 | -27.8% |
| 2004-03-02 22:27 | 2004-03-01 | BUCHI J KEVIN | Officer - Sr. Vice President & CFO | SELL | $58.50 | 16,161 | $945,462 | 55,891 | -22.4% |
| 2004-02-25 17:26 | 2004-02-24 | BALDINO FRANK JR | Director, Officer - Chairman & CEO | SELL | $57.41 | 40,000 | $2,296,552 | 272,149 | -12.8% |
| 2004-02-20 21:18 | 2004-02-19 | GREENACRE MARTYN D | Director | OPT+S | $57.45 | 5,000 | $287,237 | 0 | 0.0% |
| 2003-12-19 00:18 | 2003-12-16 | SAVINI CARL A | Officer - Sr. VP, Human Resources | SELL | $48.05 | 8,780 | $421,851 | 2,500 | -77.8% |
| 2003-12-19 00:16 | 2003-12-17 | OSBORN JOHN E | Officer - Sr. VP, General Counsel & Sec. | SELL | $48.00 | 8,214 | $394,272 | 2,500 | -76.7% |
| 2003-12-01 23:42 | 2003-12-01 | GREBOW PETER E | Officer - Sr VP,Worldwide Technical Ops. | OPT+S | $47.31 | 9,183 | $434,423 | 22,847 | 0.0% |
| 2003-11-24 23:24 | 2003-11-21 | OSBORN JOHN E | Officer - Sr. VP, General Counsel & Sec. | SELL | $46.24 | 3,857 | $178,359 | 12,500 | -23.6% |
| 2003-09-22 21:34 | 2003-09-19 | WITZEL HORST | Director | OPT+S | $49.19 | 10,000 | $491,911 | 0 | 0.0% |
| 2003-09-19 21:19 | 2003-09-19 | GREENACRE MARTYN D | Director | OPT+S | $49.49 | 5,000 | $247,425 | 0 | 0.0% |
| 2003-09-15 23:23 | 2003-09-15 | FEENEY ROBERT J | Director | OPT+S | $48.09 | 10,000 | $480,897 | 0 | 0.0% |
| 2003-09-09 23:15 | 2003-09-08 | ROCHE ROBERT P JR | Officer - Sr. Vice President | SELL | $48.40 | 2,812 | $136,101 | 0 | -100.0% |
| 2003-09-09 23:01 | 2003-09-08 | OSBORN JOHN E | Officer - Sr. VP, General Counsel & Sec. | SELL | $48.40 | 1,670 | $80,828 | 0 | -100.0% |
How to Interpret $CEPH Trades
Not every insider transaction in CEPH is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CEPH shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for CEPH
Insider activity data for CEPH is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CEPH, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.